This is a bit premature, but this is a 2018 paper on Phase 3 success rates broken down by category:
https://academic.oup.com/biostatistics/ ... 73/4817524
Obviously Geron has some special factors (e.g. the large number of previous failed trials), but at least knowing the average success rate gives us some kind of baseline. Oncology is a tough category, but the approval rate is going up.
The odds of Phase 3 success in oncology
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam